Studying aerosol emission of the COVID-19 virus in healthcare settings
- Conditions
- COVID-19 (SARS-CoV-2 infection)Infections and Infestations
- Registration Number
- ISRCTN21447815
- Lead Sponsor
- orth Bristol NHS Trust
- Brief Summary
2021 Preprint results in https://doi.org/10.1101/2021.01.29.21250552 non-peer-reviewed aerosol emission results in preprint (added 19/03/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34700360/ manual facemask ventilation quantitative evaluation (added 27/10/2021) 2021 Preprint results in https://doi.org/10.1101/2021.12.12.21267658 tracheal intubation and extubation sequences quantitative evaluation in preprint (added 16/12/2021)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 600
Patients:
1. Undergoing procedure that is potentially aerosol-generating
2. Aged over 18
3. Have capacity
Healthy volunteers:
1. Have capacity to consent to the study
2. Aged over 18
Patients:
1. Unable to read/understand PIS (either printed version or via translator)
2. Unable to consent
Healthy volunteers:
1. Flu-like symptoms (fevers, temperature, new cough, sore throat, loss of smell, breathing difficulties) in the 48 hours prior to study enrolment
2. Clinical contraindication to the procedure being performed
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Distribution of aerosol produced during routine or simulated procedures measured using Aerodynamic Particle Sensors during the procedure, and for up to 10 minutes after<br>2. Distribution of aerosol produced during routine or simulated procedures measured using Optical Particle Sensors during the procedure, and for up to 10 minutes after
- Secondary Outcome Measures
Name Time Method Distribution of aerosol produced and dissemination measured with Aerodynamic and Optical Particle sensors across a clinical room during procedures and for up to 1 hour after